RWJBarnabas Health and Rutgers Cancer Institute have named a successor for Linda Tanzer, who will retire after 30 years as chief financial and administrative officer and deputy director for ...
New data offers impactful clinical insights across Hodgkin lymphoma, diffuse large B-cell lymphoma, chronic lymphocytic leukemia, and real-world disparities analyses NEW BRUNSWICK, N.J., Dec. 2, 2025 ...
SECAUCUS, N.J. and NEW BRUNSWICK, N.J., Sept. 22, 2025 /PRNewswire/ -- Haystack Oncology, a Quest Diagnostics (DGX) company, today announced a research collaboration with the Rutgers Cancer Institute ...
RWJBarnabas Health together with Rutgers Cancer Institute unveils the Jack & Sheryl Morris Cancer Center, the first and only freestanding cancer hospital in New Jersey during a media tour on Tuesday, ...
Rutgers Cancer Institute of New Jersey researcher Michael L. Gatza, PhD, has received a $200,000 V Scholar Grant from The V Foundation for Cancer Research to explore a cell pathway in triple-negative ...
Steve Adubato talks with Steven K. Libutti, MD, Sr. Vice President of Oncology Services at RWJBarnabas Health and William N. Hait, Director at Rutgers Cancer Institute, about the partnership between ...
H. John Pounardjian has been named chief financial and administrative officer of Rutgers Cancer Institute in New Brunswick, N.J., effective June 1. Mr. Pounardjian will also serve as deputy director ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results